Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.31M Buy
14,000
+1,000
+8% +$138K 0.81% 41
2026
Q1
$1.82M Sell
13,000
-2,000
-13% -$364K 0.82% 45
2025
Q4
$2.69M Buy
15,000
+1,447
+11% +$247K 1.04% 33
2025
Q3
$2.75M Sell
13,553
-6,047
-31% -$1.31M 0.98% 44
2025
Q2
$3.7M Buy
19,600
+4,500
+30% +$836K 1.4% 16
2025
Q1
$3.54M Buy
+15,100
New +$5.23M 1.44% 13

Other funds holding RH

Formula Growth's RH Position: Q2 2026 in Review

Formula Growth increased its RH (RH) stake by 7.7% in Q2 2026, buying an estimated $138K and bringing the position to 14,000 shares worth $2.31M. The position accounts for 0.81% of the portfolio, ranked #41.

Formula Growth first reported a position in RH in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.7M in Q2 2025. 371 funds tracked by Wall St. Rank hold RH as of Q2 2026.

  • Formula Growth held 14,000 shares of RH worth $2.31M as of Q2 2026.
  • Formula Growth bought 1,000 RH shares in Q2 2026, an estimated $138K.
  • RH made up 0.81% of Formula Growth's portfolio in Q2 2026, its #41 holding.
  • Formula Growth first reported a position in RH in Q1 2025 and has held it in 6 quarters since.
  • Formula Growth's RH position peaked at $3.7M in Q2 2025.
  • 371 funds tracked by Wall St. Rank held RH as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.